Home Blog
PHTS International Care Guidelines are published!
We are excited to share our academically agreed-upon International Care Guidelines. This was a multi-year, multi-center project that researchers, clinicians, patient advocates, and many reviewers worldwide worked very hard to develop and publish. We expect this publication will continue to evolve as time to diagnosis and diagnostic capabilities are improving. Information is power. Our foundation would like to dedicate this publication to Dr. Charis Eng. Her legacy lives on. We would also like to thank Claudio Ales, President of PTEN Italia, who was also integral in advising us on this international collaboration.
Loading...
Loading...
Reload document 
Open in new tab We are excited to announce that we will offer two scholarships to honor our Canadian friends Kingston and Luka and their incredible Moms who hiked Kilimanjaro for PTEN.
We are providing two $500 scholarships to Canadian families in need to honor these fantastic heroes.
You can apply for the Kingston and Luka scholarships by clicking here.
Support Students with PHTS
Our students often have unique needs, so we worked with our PHTS experts to create this document that families can share with teachers, providers, or other providers interacting with our students. Adults may also benefit from recommended interventions.
Supporting-students-with-PHTS-final-KAYou can also link to the document by clicking here.
Anniversary Celebration Scholarships
We are celebrating ten years of serving you and want to give back. We are offering two $1000 scholarships to families with the greatest need. This application is open to all patients diagnosed with PTEN Hamartoma Tumor Syndrome.
Apply by clicking here.
2024 Symposium Scholarship Applications
We hope to see you at the symposium; please don’t hesitate to apply if you need help getting there. Scholarships will be handed out at the event.
Apply here:
Join us for our 8th Annual Patient and Scientific Symposium, October 23-24, 2024, Huntsville, AL
Sign up today: (Please note that spaces are limited to 100, and our room block will be extended by blocks of five as they fill up. These rooms are non-refundable.)
Your Genetics and Health History Matter
Because it informs research and can provide insights into your risk for certain diseases and conditions.
Join us for a webinar empowering you with knowledge on why your story matters and how to share it.
Special Guest. Dr. Tuya Pal
Tuya Pal, MD, is a Professor in the Division of Genetic Medicine in the Department of Medicine at Vanderbilt University Medical Center. Her research interests have consistently focused on epidemiological studies of inherited cancer predisposition.
Dr. Pal’s research has spanned the cancer prevention and control continuum, with evaluations of genetic etiology, cancer risks, and outcomes, including efforts among underserved populations. She has also evaluated the care delivery of genetic services, including identification, access, utilization, quality of care, and follow-up care. Her efforts among underserved ethnically and racially diverse populations of young women with breast cancer have focused on both the prevention and control of cancer and care delivery, including developing educational and outreach efforts to enhance awareness about inherited breast cancer.
Dr. Pal created the Inherited Cancer Registry (ICARE) initiative. This academic-community partnership provides outreach and education at both the patient and provider level. This effort has resulted in tremendous growth of the research registry, with the recruitment of over 2,000 high-risk participants, including more than 1,000 BRCA carriers.
Click on the following link to join us for the upcoming webinar on 8/31/23 @ 12:30 Central >> Sign Up Here.
This effort is made possible by Global Genes, The Rare Disease Diversity Coalition, and The National Genetics Education and Family Support Center.
Join our PTEN Family Research Council
Do you want to make a difference in research? We need you!
Sign up for our family research council today. (Click Here)
